Abstract We recently demonstrated that granule cells located in the dorsal dentate gyrus (dDG) are activated by neurons located in the lateral supramammillary nucleus (SumL) during paradoxical sleep (PS) hypersomnia. To determine whether these neurons are glutamatergic and/or GABAergic, we combined FOS immunostaining with in situ hybridization of vesicular glutamate transporter 2 (vGLUT2, a marker of glutamatergic neurons) or that of the vesicular GABA transporter (vGAT, a marker of GABAergic neurons) mRNA in rats displaying PS hypersomnia (PSR). We found that 84 and 76 % of the FOS? SumL neurons in PSR rats expressed vGLUT2 and vGAT mRNA, respectively. Then, we examined vGLUT2 and FOS immunostaining in the dorsal and ventral DG of PSR rats with a neurochemical lesion of the Sum. In PSRlesioned animals but not in sham animals, nearly all vGLUT2? fibers and FOS? neurons disappeared in the dDG, but not in the ventral DG (vDG). To identify the pathway (s) responsible (s) for the activation of the vDG during PS hypersomnia, we combined Fluorogold (FG) injection in the vDG of PSR rats with FOS staining. We found a large number of neurons FOS-FG?, specifically in the medial entorhinal cortex (ENTm). Altogether, our results suggest that SumL neurons with a unique dual glutamatergic and GABAergic phenotype are responsible for the activation of the dDG during PS hypersomnia, while vDG granule neurons are activated by ENTm cortical neurons. These results suggest differential mechanisms and functions for the activation of the dDG and the vDG granule cells during PS.
Introduction
Paradoxical sleep (PS) is characterized by muscle atonia, rapid eye movements (REM), and cortical and hippocampal activation (Jouvet et al. 1959) . We recently showed that the dentate gyrus (DG) is strongly activated during PS. Indeed, a large number of neurons with an increased expression of FOS, BDNF, COX2, and ARC, known markers of activation and/or synaptic plasticity, are selectively observed, specifically in the DG in PS hypersomniac rats compared with control and PS-deprived animals (Renouard et al. 2015) . We further found out combining FOS labelling after PS hypersomnia with retrograde tracer injection in the dorsal part of the DG (dDG) that the lateral part of the supramammillary nucleus (SumL) is the only brain structure-containing a large number of double-labelled neurons. Finally, we showed that a neurotoxic lesion of the Sum drastically decreases the number of FOS? granule cells in the dDG in PS hypersomniac animals (Renouard et al. 2015) . These results suggest that SumL neurons are responsible for the activation of dDG granule cells during PS hypersomnia. Still, the neurotransmitter content of these neurons remained to be identified. A number of results suggested that they might display a unique dual glutamatergic and GABAergic phenotype. Indeed, after injection of the anterograde tracer BDA in the SumL, all terminals located in the dDG coexpressed vesicular GABA/glycine transporter (vGAT) and vesicular 2 glutamate transporter (vGLUT2), markers of GABAergic and glutamatergic neurons, respectively. The ventral dentate gyrus (vDG) contained less GABA/ glutamate terminals coming from the SumL and received additional strictly glutamatergic projection from the medial part of the Sum (SumM) (Soussi et al. 2010) . In view of all these results, our aim in this study was to determine whether the SumL neurons-expressing FOS during PS hypersomnia are, indeed, glutamatergic and GABAergic and whether they can be also responsible for the activation of the ventral DG (vDG) in addition to that of the dDG. To this aim, we used a combination of FOS immunostaining and in situ hybridization of vGLUT2 or vGAT mRNA in PS hypersomniac rats (PSR). In addition, we analyzed the distribution of the vGLUT2? fibers and that of the FOS? neurons in the dDG and vDG of PSR animals after neurotoxic lesions of the Sum. Finally, we combined FOS labelling in PSR rats with retrograde tracer injection in the vDG.
Materials and methods
All experiments were conducted in accordance to the French and European Community guidelines for the use of animals in research and approved by the institutional animal care and use committee of the University of Lyon 1 (protocols BH 2006-09 and BH 2006-10) .
Sprague-Dawley male rats were housed individually in recording barrels under a constant 12 h light-dark cycle (light on from 07:00 a.m. to 07:00 p.m.). Room temperature was maintained at 21 ± 1°C, and standard rodent food and water were available ad libitum throughout the experiment.
Animals and surgery
28 Male Sprague-Dawley rats (260-300 g, Charles River, n = 12 for vGLUT2/FOS staining, n = 4 for vGAT/FOS staining, n = 8 for lesions experiments, n = 4 for Fluorogold injections) were implanted with electroencephalographic (EEG) and electromyographic (EMG) electrodes under ketamine (Virbac Santé Animale, 100 mg/kg, i.p) and xylazine (Bayer, 50 mg/kg, i.p) anaesthesia. Lidocaïne (Xylovet, Ceva Santé Animale) injected subcutaneously was used for analgesia. Three stainless steel screws were fixed in the parietal, frontal, and occipital parts of the skull, while the reference electrode for unipolar EEG recording was fixed on the cerebellum bone. Two wire electrodes were inserted into the neck muscles for bipolar EMG recordings. All leads were connected to a miniature plug (Plastics One Inc.) that was cemented on the skull.
Lesion
Male Sprague-Dawley rats (260-300 g, Charles River) were anesthetized as described above and placed in a stereotaxic apparatus. The lesions were made bilaterally in four rats by passing a 10 lA continuous current for 10 min through a micropipette-containing ibotenic acid (25 mmol/ L in distilled water adjusted at pH 8, Tocris) in each Sum (coordinates: AP: -4.5 mm to Bregma, ML: ?0.6 mm lateral to midline, DP: 8.3 mm from the brain surface). Four sham rats were subjected to the same protocol with a micropipette-containing 0.9 % NaCl. All animals were then implanted for EEG and EMG recordings as described above.
Tracer injections
Male Sprague-Dawley rats (260-300 g, Charles River, n = 4) were anesthetized as described above and placed in a stereotaxic apparatus. Glass micropipettes (4-5 lm O.D.) were backfilled with Fluorogold (FG, Fluoprobe, diluted in distilled water at 8 mmol/L and pH 6) and lowered in the vDG (coordinates: AP -6 mm to Bregma, ML ?4.1 mm lateral to midline, DP: 6.8 mm from the brain surface). FG was ejected during 15 min with a continuous current of ?2 lA. Animals were then implanted for EEG and EMG recordings as described above and submitted to PS deprivation and recovery procedure (see below) before being perfused.
Polygraphic recordings
Animals recovered from surgery during 1 week in a Plexiglas jar before being habituated to the recording conditions for 3 days. Rats were connected to a cable attached to a slip-ring commutator to allow free movement of the animal within the jar. EEG and EMG recordings were collected on a computer via a CED interface using the Spike 2 software (Cambridge Electronic Design, Cambridge, UK).
PS deprivation and recovery protocol
PS deprivation was performed using the flowerpot method (Verret et al. 2003) . Rats were divided in three groups: control (PSC, n = 4), deprived of PS for 3 days (PSD, n = 4), and rats allowed recovering after such deprivation (PSR, n = 20). PSC animals remained in their standard cage throughout the experiment. After 48 h of baseline recordings, PSD and PSR rats were placed at 10:00 a.m. in a standard container filled with water (2-3 cm depth) and containing three platforms (6.2 cm diameter, 7-12 cm height) spaced 7-8 cm apart, so that rats were able to easily move between them. For the FOS-vGLUT2, FOS-vGAT, and FOS-FG experiments, animals were put on a single platform. During PSD, food and water were available ad libitum and the container was cleaned daily. The third day, PSR animals were removed from their cages at 10:00 a.m. and put on a dry bed of woodchips in recording jars to allow PS recovery. The animals used for the FOSvGLUT2, FOS-vGAT, and FOS-FG experiment were perfused 3 h and the other PSR animals 6 h after the onset of PS recovery.
Perfusion, fixation, and sectioning
Animals were perfused with a Ringer's lactate solutioncontaining 0.1 % heparin followed by 500 mL of a fixative solution composed of 4 % paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). Brains were postfixed for 12 h at 4°C and then stored for 2 days at 4°C in a PB buffer-containing 30 % sucrose and 0.1 % sodium azide (Sigma-Aldrich). Brains were rapidly frozen in methylbutane (Sigma-Aldrich) cooled with dry ice and sliced on a cryostat (Microm). For immunohistochemistry experiments, brains were cut in 25 lm-thick coronal sections and stored in PB-containing 0.9 % NaCl, 0.3 % Triton X-100, and 0.1 % sodium azide (PBST-Az). For in situ hybridization experiments, brains were cut in 30 lm-thick coronal sections and stored at -20°C in an RNAse-free cryoprotectant solution consisting of 20 % Glycerol, 30 % Ethylene Glycol, and 0.05 % RNase inhibitor in a 50 mM potassium-phosphate buffer (Sigma-Aldrich).
FOS immunohistochemistry combined with vGLUT2 or vGAT in situ hybridization
The recombinant plasmid (pCRII-TOPO, Invitrogen)-containing the vGLUT2 cDNA was linearized using Not I and Hind III (New England Biolabs) and transcribed using SP6 and T7 RNA polymerases (for antisense and sense riboprobes, respectively). The vGAT riboprobes were prepared by PCR as previously described (Gandrillon et al. 1996) . All riboprobes were transcribed using a non-radioactive RNA labelling kit (Roche Diagnostic) following manufacturer's instructions. Digoxigenin-labelled riboprobes were then stored at -20°C in a hybridization buffer. As described before (Sapin et al. 2009 ), brain sections were successively incubated with a rabbit antiserum to FOS (1:3000 for vGLUT2, 1:4000 for vGAT, Merck), in 10 mM PB-containing 0.9 % NaCl and 0.3 % Triton-1009 (PBST) for 18 h at room temperature; a biotinylated goat antirabbit IgG solution (1:1000, Vector Laboratories); and an ABC-HRP solution (1:1000, Elite kit, Vector Laboratories), both for 90 min at room temperature. Then, sections were immersed for around 15 min in a 0.05 M TrisHCl buffer-containing 0.025 % 3,3-diaminobenzidine-4 HCl (DAB, Sigma-Aldrich) and 0.003 % H 2 O 2 . Sections were rinsed three times in PBST between each step. Then, they were incubated in PBST-containing 10 mM dithio-threitol (DTT, Sigma-Aldrich) twice for 10 min and in a standard saline citrate solution (SSC 2X) for 10 min. All the buffers excepting DTT contained 0.2 % of RNase inhibitor (Sigma-Aldrich). Sections were then placed overnight at 65°C in the hybridization buffer consisting of 150 mM NaCl, 8 mM Tris-HCl, 1 mM Tris-Base, 6 mM NaH 2 PO 4 , 5 mM Na 2 HPO, 5 mM EDTA, 50 % formamide, 10 % dextran sulphate, yeast tRNA (Sygma type III, 1 mg/mL, Sigma-Aldrich), 0.02 % ficoll, and 0.02 % polyvinylpyrorolidone-containing 0.5 lg/mL of the digoxigenin-labelled probe. Sections were washed in SSC 1X, 50 % formamide, and 0.1 % Tween-20 twice for 20 min at 55°C and treated with 10 lg/ll RNase A (USB Corporation) in Tris 10 mM-containing 1 mM EDTA and 500 mM NaCl for 15 min at 37°C. After three washes in PBST, sections were incubated overnight with an antidigoxigenin antibody conjugated to alkaline phosphatase (1:2000, Roche Diagnostic) in PBST-containing 0.2 % blocking agent (Roche Diagnostic). Then, they were washed twice in PBST, once in PBS 10 mM, and in a buffer-containing 1 M Tris-HCl, 1 M NaCl, 500 mM MgCl 2 , and 1 % Tween-20. Each washing lasted 10 min. Sections were then incubated at 37°C in the same buffercontaining nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) (20 ll/mL, Roche Diagnostic). After *4 h of incubation in the revelation buffer, sections were washed in PBST twice for 10 min. Finally, the sections were mounted on glass slides, dried, and coverslipped with Vectamount (Vector Laboratories). Controls in the absence of primary antibodies (anti-FOS and anti-digoxigenin) or with the sense probe were run to ensure the specificity of the labelling.
vGLUT2, FOS, FOS-FG, and NeuN immunohistochemistry
Sections of PSR rats were incubated in a rabbit antiserum to vGLUT2 (1:10,000, Synaptic Systems) or to FOS (1:5000 for PSR-lesion and sham rats, 1:10,000 for PSR rats injected with FG, Merck) in PBST-Az for 3 days at 4°C. Then, sections were incubated in a biotinylated antirabbit IgG solution (1:1000 in PBST, Vector Labs) and an ABC-HRP solution (1:1000 in PBST; Elite kit, Vector Labs) for 90 min at room temperature. Finally, sections were immersed in a 0.05 M Tris-HCl buffer (pH 7.6)-containing 0.025 % 3,3 0 -diaminobenzidine-4 HCl (DAB, Sigma), 0.003 % H 2 O 2 , and 0.6 % nickel ammonium sulphate to obtain a black reaction product. Sections were rinsed three times in PBST between each step. FOS-stained sections of PSR rats injected with FG were incubated in the rabbit antiserum to FG (1:15,000, US Biological) in PBSTAz for 3 days at 4°C. Then, sections were incubated in a biotinylated antirabbit IgG solution (1:1000 in PBST, Vector Labs) and an ABC-HRP solution (1:1000 in PBST, Elite kit, Vector Labs) for 90 min at room temperature before being immersed in a DAB solution without nickel to obtain a brown reaction product.
Sections at the level of the Sum in lesion and sham animals were incubated in a mouse antiserum to NeuN (1:20,000, Chemicon), followed by an incubation in a biotinylated antimouse IgG solution (1:1000 in PBST, Vector Labs), ABC-HRP solution, and DAB nickel. Sections were then mounted and counterstained with neutral red.
Analysis of the sleep-wake states
Vigilance states were discriminated using EEG and EMG data as previously described (Sapin et al. 2009 ). State classification was done by a visual check of polygraphic signals. For each rat, the last 3 or 6 h of EEG/EMG recordings before perfusion were analyzed by 5 s epochs to determine quantities of waking (WK), slow-wave sleep (SWS), and PS. WK was characterized by a low-amplitude EEG and a sustained EMG activity; SWS was identified by high-voltage slow waves (1.5-4.0 Hz) and spindles (10-14 Hz) without phasic muscle activity; PS was characterized by theta rhythm (4-9 Hz) and muscle atonia. Hypnograms were obtained using the Spike-2 software (CED).
Analysis of immunostaining
The atlas of Swanson was used as a reference for all structures (Swanson 1992) .
Drawings of double-or single-labelled sections were made with an Axioscope microscope (Zeiss) equipped with a motorized X-Y-sensitive stage and a video camera connected to a computerized image analysis system (Mercator, ExploraNova). The number of double-labelled FOSvGLUT2?, FOS-vGAT?, and FOS-FG? neurons was quantified on two hemi-sections at the level of the Sum for all animals (-4.45 and -4.60 mm to Bregma). The number of double-labelled FOS-FG? neurons was also quantified on two hemi-sections at the level of the medial septum (MS) and the diagonal band nucleus (NBD, ?0.10 and -0.26 mm to Bregma), the lateral hypothalamic area (LHA, -3.25 and -3.90 mm to Bregma), the entorhinal cortex (ENT, -6.50 and -7.10 mm to Bregma), and the interpeduncular nucleus (IPN, -6.06 and -6.85 mm to Bregma).
In the DG, the number of FOS? neurons and the level of expression of the vGLUT2 protein evaluated by optical density were quantified on four hemi-sections: -3.90 and -5 mm to Bregma for the dDG; -5.65 and -6.06 mm to Bregma for the vDG. Optical density was determined using the ImageJ software in the granular layer of the DG and normalized using the DG molecular layer reading.
Statistical analysis
Analysis of variance (Kruskal-Wallis test following by Mann-Whitney tests) was performed on the different vigilance states, the number of labelled neurons, and on the staining of vGLUT2 fibers for each structure across the experimental conditions (PSC, PSD, PSR, PSR-Sham and PSR-Lesion). All statistics were performed using the StatView software.
Results

Quantification of sleep
During the last 150 min before sacrifice, PSR animals used for FOS-vGLUT2 (n = 4), FOS-vGAT (n = 4) and FOS-FG experiments (n = 4) spent significantly more time in PS than PSC (n = 4) (39.1 ± 2.4 and 7.05 ± 1.8 %, respectively, P = 0.0041) and PSD (n = 4) (1.5 ± 1.5 %, P = 0.0041) animals (Fig. 1c) . PSD rats spent significantly less time in PS than PSC rats (P = 0.0433, Fig. 1e, f) . PSR animals exhibited significantly less WK (18.3 ± 3.4 %) than PSC (49.3 ± 8.5 %, P = 0.0188) and PSD (66.8 ± 4.6 %, P = 0.0041) animals (Fig. 1a, b) . No difference in SWS quantities was observed between the three groups of animals (PSC: 43.6 ± 7.0 %, PSD: 31.7 ± 3.1 %, PSR: 42.5 ± 2.7 %, P = 0.0873, Fig. 1c,  d ). The PSR-lesioned (n = 4) and sham rats (n = 4) displayed the same amounts of PS, SWS, and WK either in baseline condition (P = 0.1489, =0.3865, =0.3865, respectively) or during PS hypersomnia (P = 0.0833, [ 0.9999, =0.1489, respectively).
Distribution of the FOS1, FOS/vGLUT21, and FOS/vGAT1 double-labelled neurons in the supramammillary nucleus
To determine the level of activity of Sum neurons during PS hypersomnia, we quantified the number of neurons immunopositive for FOS in PSC (n = 4), PSD (n = 4) and PSR rats (n = 4).
As previously shown (Renouard et al. 2015; Sapin et al. 2010) , a large number of FOS-labelled cells were counted in the SumL specifically in PSR rats (P = 0.0308, Table 1 ).
In contrast, a small and similar number of FOS-labelled cells was observed between the three groups of animals in the SumM (P = 0.1462, Table 1 ).
To identify the neurochemical nature of the Sum neurons activated during PS hypersomnia, we compared the distribution of FOS/vGLUT2? neurons in PSC, PSD, and PSR rats. No difference in the number of FOS/vGLUT2 double-labelled cells was observed in the SumM between the three groups of animals (PSC: 5.2 ± 3.3, PSD: 15.2 ± 5, PSR: 12 ± 4.4, P = 0.2468 (Table 1 ; Fig. 2a-c,  e-f) . In contrast, the number of FOS/vGLUT2 doublelabelled cells was significantly higher in the SumL of PSR (94.5 ± 11.9) than of PSC (22 ± 8, P = 0.0209) and PSD animals (29.5 ± 11.5, P = 0.0209). The double-labelled cells in the SumL constituted 84.2 % of the total number of FOS? cells in PSR animals (Table 1 ; Fig. 2a-c, e-f ). Since it has been shown that vGAT colocalizes with vGLUT2 in SumL neurons, we additionally counted the number of FOS/vGAT? neurons in the Sum of another group of PSR rats (n = 4). We found that 76 % of the FOS? cells located in the SumL were vGAT? in PSR animals (109 ± 25.1, Fig. 2d, g-h) . In contrast, a few FOS-vGAT double-labelled neurons were observed in the SumM of PSR rats (5.5 ± 0.9).
Effect of Sum lesion on the distribution of the vGLUT2 labelled fibers in the dentate gyrus
We compared the level of expression of the vGLUT2 protein in the dDG and vDG of PSR rats with a bilateral iontophoretic injection of ibotenic acid (n = 4) or NaCl (n = 4) in the Sum. The Sum was left intact in PSR-sham animals, while it was entirely lesioned in those injected with ibotenic acid (Fig. 3i) . In sham animals, a very high number of vGLUT2 immunoreactive fibers were localized in the supragranular layer of the DG, whereas nearly no fibers were observed in the molecular and the polymorph layers (Figs. 3a, 4a ).
In the PSR-lesioned rats, very few vGLUT2? fibers remained in the dDG and a strong reduction of the optic density (relative staining: 28.1 ± 3.6) was measured compared with PSR-sham rats (relative staining: 100 ± 14.6, P = 0.0209, Fig. 3a-d, j) . In contrast, only a small non-significant decrease in the optic density was found in the vDG between the two groups of animals (PSRlesioned: 87.6 ± 7.4, PSR-sham: 100 ± 25.5, P = 0.3865, Fig. 4a-d, j) . However, the distribution of vGLUT2 fibers was not similar in the vDG of lesioned and sham rats. Indeed, vGLUT2 staining strongly decreased specifically in the supragranular layer of the DG and remained similar in the granular layer itself (Fig. 4a-d) .
Number of FOS1 neurons in the dorsal and ventral dentate gyrus of PSR rats with a Sum lesion
The number of FOS? neurons was strongly and significantly decreased in the dDG of the lesioned compared with the sham rats (20.2 ± 6.4 versus 153.7 ± 18.8, P = 0.0209, Figs. 3e-h, j, 4i). In contrast, only a small non-significant decrease in the number of FOS? neurons was observed in the vDG in the lesioned (235.2 ± 27.2) versus the sham rats (311 ± 23, P = 0.0833, Fig. 4e-j) .
Localization of the FOS1 neurons projecting to the vDG in PSR animals
After FG injection in the vDG (n = 4, Fig. 5g) , only a small number of double-labelled cells were observed in the SumL (4 ± 1.1). No or only a few number of double-labelled neurons were observed in other afferent structures to the vDG, like the medial septum (MS, 2.2 ± 0.6), the lateral hypothalamus (LHA, 4.5 ± 1.7), the SumM (0.5 ± 0.3), the lateral entorhinal cortex (ENTl, 3.2 ± 1.9), and the interpeduncular nucleus (IPN, 1.7 ± 0.6) (Fig. 5h) . In contrast, a very large number of double-labelled FG/FOS? cells were observed in the medial entorhinal cortex (ENTm, 128.2 ± 32.4). The double-labelled cells constituted 37.2 ± 7.4 and 19 ± 2.5 % of the total number of FG and FOS? cells, respectively. 
Discussion
We report here for the first time that around 80 % of the FOS? neurons localized in the SumL after PS hypersomnia express vGLUT2 or vGAT mRNA strongly suggesting that they are coexpressed in the same cells. We further demonstrate that all vGLUT2 fibers localized in the dorsal but not the ventral DG originate from the Sum. Besides, we show that the Sum is responsible for the activation of the dorsal but not the ventral DG granule cells during PS hypersomnia. Finally, we demonstrate that the ENTm contains a very large number of FOS? neurons projecting to the vDG in PSR rats. Altogether, our results indicate that during PS hypersomnia, GABA/glutamatergic neurons located in the SumL activate dDG granule cells, while neurons located in ENTm activate vDG granule cells.
Our results complete and extend our previous studies showing, in rats, the presence of numerous FOS-labelled cells in the dorsal part of the DG and in the SumL after PS hypersomnia (Renouard et al. 2015; Sapin et al. 2010) . We further show for the first time that 84 and 76 % of the SumL FOS-labelled neurons express vGLUT2 and vGAT, respectively. Although a technologically challenging triple staining would be necessary to directly prove it, our results strongly suggest that SumL neurons activated, during PS, have a dual GABA/glutamatergic phenotype. In agreement with our results, it has been shown that a large number of SumL neurons express GAD65 (Soussi et al. 2010 ). In addition, using retrograde tracing of [3H] D-aspartate from the DG, numerous labelled neurons have been observed in the SumL suggesting that the SumL-DG pathway is glutamatergic (Kiss et al. 2000) . Furthermore, 86 % of the total number of retrogradely labelled neurons located in the SumL after an injection of a retrograde tracer in the dDG expresses GAD65 mRNA (Soussi et al. 2010) . We also previously showed that 28 % of the retrogradely labelled neurons in the SumL after a dorsal DG injection are FOS? after PS hypersomnia (Renouard et al. 2015) . Finally, it has been shown that all anterogradely labelled fibers localized in the DG after injection of an anterograde tracer in the SumL co-express vGAT, GAD65, and vGLUT2 clearly confirming that the SumL-DG pathway is both GABA and glutamatergic. Altogether, these results indicate that most SumL neurons projecting to the dDG including those activated during PS hypersomnia have a dual GABA/glutamate phenotype.
In addition, to determine whether SumL neurons are at the origin of all vGLUT2 fibers and induce FOS labelling after PS hypersomnia both in the dDG and vDG, we quantified the number of vGLUT2 fibers and FOS-labelled neurons in these two parts of the DG after full lesions of the Sum. Furthermore, we determined whether the Sum contains retrogradely labelled FOS? neurons after injection of Fluorogold in the vDG. We found out that Sum lesions induce a nearly complete disappearance and, in contrast, a non-significance decrease of FOS-labelled neurons in the dorsal and ventral part of the DG, respectively. vGLUT2-labelled fibers also completely disappeared in the dorsal but not in the ventral DG, in which they specifically decreased in the supragranular but not in the granular layer itself. Finally, we found only a small number of FOS? retrogradely labelled neurons in the SumL after injection of Fluorogold in the vDG. Our results are in line with the previous studies showing using anterograde tracer injection that the SumL project more densely to the dorsal than to the ventral DG (Ohara et al. 2013; Soussi et al. 2010; Vertes 1992) . They also indicate that all vGLUT2 fibers present in the dorsal but not in the ventral DG originate from Sum neurons. In summary, our results clearly show for the first time that during PS hypersomnia, SumL neurons are fully responsible for the activation of dDG neurons, while they play a minor role for that of the vDG neurons.
After injection of Fluorogold in the vDG, a high number of FOS? retrogradely labelled neurons were specifically observed in the ENTm. Only a few double-labelled neurons were observed in the other afferents to the vDG, including the Sum. These results are in line with our previous data showing that the ENTm contains a very large number of FOS? neurons during PS hypersomnia compared with PS deprivation and control conditions (Renouard et al. 2015) . These results contrast with those obtained for the dDG b Fig. 3 vGLUT2? ) and a PSR rat with a lesion of the Sum (f, h). g and h show the area inside the rectangle in (e) and (f) at a higher magnification. The Sum lesion causes a dramatic reduction in the number of FOS? neurons in the dDG. i Illustration of a representative neurotoxic lesion of the Sum on a section immunostained with NeuN. j Mean ± SEM optic density of vGLUT2 staining and number of FOS? neurons in dDG in rats with a Sum lesion (n = 4) relative to PSR-sham animals (n = 4). Significance Kruskal-Wallis followed by Mann-Whitney. *P \ 0.05. CA3 field CA3, Ammon's Horn, DGlb dentate gyrus, lateral blade, DGlb-mo dentate gyrus, lateral blademolecular layer, DGlb-sg dentate gyrus, lateral blade-granule cell layer, DGmb dentate gyrus, medial blade, DGmb-mo dentate gyrus, medial blade-molecular layer, DGmb-po dentate gyrus, medial bladepolymorph layer, DGmb-sg dentate gyrus, medial blade-granule cell layer, LM lateral mammillary nucleus, MM medial mammillary nucleus, medial part, MnM medial mammillary nucleus, median part, pm principal mammillary tract, SumL lateral supramammillary nucleus, SumM medial supramammillary nucleus, V3 third ventricle. ) and a PSR rat with a lesion of the Sum (f, h). g and h Show the area inside the rectangle in (e) and (f) at a higher magnification. The Sum lesion does not cause a reduction in the number of FOS? neurons in the vDG. i Schematic distribution of FOS? (black dots) neurons in the dDG and vDG on a coronal section in a sham (left) and a lesioned (right) rat. Note the strong decrease in the number of FOS? neurons in the dDG but not the vDG. j Mean ± SEM optic density of vGLUT2 staining and number of FOS neurons in vDG in rats with a Sum lesion (n = 4) relative to PSR-sham animals (n = 4). CA3 field CA3, Ammon's Horn, dDG dorsal dentate gyrus, DGlb dentate gyrus, lateral blade, DGlb-mo dentate gyrus, lateral blade-molecular layer, DGlb-sg dentate gyrus, lateral bladegranule cell layer, DGmb dentate gyrus, medial blade, DGmb-mo dentate gyrus, medial blade-molecular layer, DGmbpo dentate gyrus, medial bladepolymorph layer, DGmb-sg dentate gyrus, medial bladegranule cell layer, vDG ventral dentate gyrus. Scale bars 500 lm for (a, b, e, f); 50 lm for (c, d, g, h) showing that the SumL contains a large number of doublelabelled cells, while none were observed in the ENTm, although it contained a large number of retrogradely labelled neurons (Renouard et al. 2015) . Altogether, these results strongly suggest that the ENTm neurons are responsible for the activation of the vDG neurons during PS hypersomnia. These cells might also be at the origin of the remaining vGLUT2 innervation of the vDG after Sum lesion, since the ENTm contains vGLUT2? neurons (Wouterlood et al. 2008 ).
Functional significance
Our results strongly suggest that bipotential GABA/glutamatergic neurons of the SumL activate the granule cells of the dDG during PS hypersomnia. Furthermore, it is likely that they are also responsible for the previously reported increased expression of BDNF, ARC, and COX2 in the granule cells after PS hypersomnia (Renouard et al. 2015) . The mechanisms responsible for increased expression of these early genes during PS hypersomnia remain to be determined. Indeed, the expression of FOS and that of the other early genes are generally induced by an increase in firing of the neurons (Yassin et al. 2010) . However, activation of the SumL/ dDG pathway should induce both the release of GABA and glutamate on dentate granule cells likely resulting in no change in firing rate. Recording of granule cells has shown that they are nearly not active during waking and that they are slightly more active during sleep (Neunuebel and Knierim 2012) . Supporting the hypothesis that they do not increase their activity during PS, the downstream targets of DG granule cells, the CA3 neurons do not express FOS during PS hypersomnia (Renouard et al. 2015) . In agreement with our results, LFP and unit activity recordings in the hippocampus showed enhanced dentate processing but limited CA3-CA1 coordination and a decrease in CA1 neurons firing rate during PS compared with SWS and WK (Montgomery et al. 2008) . We propose that all SumL-dDG terminals corelease GABA and glutamate during PS, but that facing GABAergic postsynaptic receptors are located only at somatic level of granule cells, whereas NMDA and AMPA glutamatergic receptors are located at dendritic level. In such case, granule cells would be inhibited and, therefore, not able to generate spikes. However, the activation on DG cells of dendritic NMDA receptors by glutamate during PS hypersomnia could induce calcium entry, activation of the MAP kinase pathway, and be responsible for the transcription of immediate early genes, including FOS, as previously described (Lerea and McNamara 1993) . Additional studies on DG neurons across the sleep-waking cycle using calcium imaging, multiunit multisites recordings, and optogenetics are needed to test such a hypothesis.
The function of the activation of DG granule cells during PS also remains to be determined. The DG is thought to play a key role in the formation of the contextual component of fear memories by discriminating similar contexts (McHugh et al. 2007) . Using the early genes expression mapping, it has been shown that the same small group of DG granule cells (2-4 %) is activated every time the animal is exposed to the same context, while different environments or tasks activate different populations of DG granule cells (Schmidt et al. 2012) . Furthermore, it has recently been shown that optogenetic reactivation of DG granule cells activated during fear conditioning is sufficient to induce freezing behavior (Liu et al. 2012) . Conversely, inactivating DG granule cells that were activated during fear conditioning by optogenetic impairs the expression of the fear memory as evidenced by the lower percentage of freezing when exposing the animals to the same context (Denny et al. 2014 ). On the other hand, it has been shown that contextual fear conditioning is impaired after PS deprivation (Ravassard et al. 2016) or inhibition of theta rhythm during PS by optogenetic silencing of medial septum GABAergic neurons (Boyce et al. 2016) . Altogether, these and our results strongly suggest that activation of DG granule cells during PS plays a role in the consolidation of emotional and spatial memory.
Our results further show that dorsal and ventral DG granule cells are activated during PS by SumL and ENTm neurons, respectively. Interestingly, it has been demonstrated that DG granule cells have different functions along the dorsoventral axis of the hippocampus: dDG neurons seem to control exploratory behavior and encoding of contextual fear memories, while vDG neurons are more implicated in anxiety-related behavior (Kheirbek et al. 2013) . Additional studies using optogenetic inhibition and activation of the granule cells of the ventral and dorsal DG activated during PS are necessary to determine whether they play a role in contextual fear memory consolidation and anxiety regulation.
In conclusion, our data strongly suggest that GABA/ glutamatergic neurons of the SumL and cortical neurons of 
